ClinicalTrials.govpublic full text
Cyclophosphamide With Biochemical Progression During Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma (MM)
multiple myeloma, lenalidomide, biochemical progression, relapsed/refractory mm, without crab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 859176
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.